Skip to main content

Table 1 Library statistics.

From: Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes

Library

#Total PETs

#uPETs

#Mappable (% over uPETs)

# PET1

#Known gene-asso. PET1 (% over PET1)

#Pathway-asso. PET1 (% over PET1) (% over known gene-asso. PET1)

B16F1 melanoma (SMT001)

91977

45465

34146 (75.1%)

32267

29439 (91.2%)

11687

(36.2%) (39.7%)

Melan-a2 melanocyte (SMN001)

68880

51352

38640 (75.3%)

36623

33005 (90.1%)

13348

(36.4%) (40.4%)

E14 Stem Cell (MoEScom)

248234

135328

97295 (71.9%)

93384

86019 (92.1%)

28311

(30.3%) (32.9%)

E17.5 embryo (SME006)

81793

41595

30883 74.3%

28387

24656 (86.9%)

9314

(32.8%) (37.8%)

  1. uPETs, PETs having unique sequences. Mappable ratio is the percentage of unique PETs that have one or more target locations in the genome. PET1 ratio refers to the percentage of mappable PETs that have unique targets in the genome. Pathway-asso. PET1 is the percentage of PET1 ditags that can be assigned to KEGG pathways.